ATE228829T1 - Tablette mit gesteuerter freisetzung - Google Patents

Tablette mit gesteuerter freisetzung

Info

Publication number
ATE228829T1
ATE228829T1 AT96908487T AT96908487T ATE228829T1 AT E228829 T1 ATE228829 T1 AT E228829T1 AT 96908487 T AT96908487 T AT 96908487T AT 96908487 T AT96908487 T AT 96908487T AT E228829 T1 ATE228829 T1 AT E228829T1
Authority
AT
Austria
Prior art keywords
controlled
release tablet
tablet
release
Prior art date
Application number
AT96908487T
Other languages
English (en)
Inventor
Cherng-Ju Kim
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Application granted granted Critical
Publication of ATE228829T1 publication Critical patent/ATE228829T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
AT96908487T 1995-02-28 1996-02-28 Tablette mit gesteuerter freisetzung ATE228829T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39579295A 1995-02-28 1995-02-28
PCT/US1996/002290 WO1996026718A2 (en) 1995-02-28 1996-02-28 Controlled release tablet

Publications (1)

Publication Number Publication Date
ATE228829T1 true ATE228829T1 (de) 2002-12-15

Family

ID=23564527

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96908487T ATE228829T1 (de) 1995-02-28 1996-02-28 Tablette mit gesteuerter freisetzung

Country Status (11)

Country Link
EP (1) EP0821582B1 (de)
JP (1) JPH11509169A (de)
AR (1) AR003928A1 (de)
AT (1) ATE228829T1 (de)
AU (1) AU722741B2 (de)
CA (1) CA2213455A1 (de)
DE (1) DE69625189D1 (de)
MY (1) MY113429A (de)
PA (1) PA8388101A1 (de)
TW (1) TW431891B (de)
WO (1) WO1996026718A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
WO1998029095A2 (en) * 1997-01-03 1998-07-09 Elan Corporation, Plc Sustained release cisapride mini-tablet formulation
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
IL150568A0 (en) 2000-02-04 2003-02-12 Depomed Inc A controlled release oral drug dosage form
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US6723340B2 (en) * 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
NZ541008A (en) 2003-01-13 2007-09-28 Dynogen Pharmaceuticals Inc Method of treating functional bowel disorders
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
MXPA06014587A (es) 2004-06-17 2007-04-27 Forest Laboratories Formulaciones de liberacion modificada de formulaciones de dosificacion oral de memantina.
BRPI0617382A2 (pt) 2005-10-14 2017-07-11 H Lundbeck As Métodos para tratar um distúrbio do sistema nervoso central em um paciente, para tratar um paciente sofrendo de condições e uma disfunção sexual, e para reduzir um retardo na eficácia terapêutica em seguida ao início do tratamento
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US20070202164A1 (en) * 2006-02-28 2007-08-30 Hutchison Medipharma Enterprises Limited Andrographis Extract Formulations
WO2010026467A2 (en) 2008-09-04 2010-03-11 Torrent Pharmaceuticals Ltd. Controlled release dosage form of high solubility active ingredient
EA201101524A1 (ru) 2009-04-20 2012-07-30 Элселикс Терапьютикс, Инк. Способ и композиция для лечения состояния, связанного с хемосенсорным рецептором
US8828953B2 (en) 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
AU2011317140A1 (en) 2010-10-19 2013-05-30 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
SG10201607085WA (en) 2011-01-07 2016-10-28 Elcelyx Therapeutics Inc Chemosensory Receptor Ligand-Based Therapies
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
JP2016520653A (ja) 2013-06-05 2016-07-14 シンクロニューロン インコーポレイテッド アカンプロサート製剤、それを用いる方法、およびそれを含む合剤
US9617230B2 (en) 2014-12-22 2017-04-11 Farmington Pharma Development Creatine prodrugs, compositions and methods of use thereof
CA3082184A1 (en) 2017-12-01 2019-06-06 Ultragenyx Pharmaceutical Inc. Creatine prodrugs, compositions and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252338A (en) * 1991-06-27 1993-10-12 Alza Corporation Therapy delayed

Also Published As

Publication number Publication date
CA2213455A1 (en) 1996-09-06
EP0821582B1 (de) 2002-12-04
MY113429A (en) 2002-02-28
DE69625189D1 (de) 2003-01-16
AU5171196A (en) 1996-09-18
EP0821582A2 (de) 1998-02-04
JPH11509169A (ja) 1999-08-17
WO1996026718A2 (en) 1996-09-06
AR003928A1 (es) 1998-09-30
AU722741B2 (en) 2000-08-10
TW431891B (en) 2001-05-01
WO1996026718A3 (en) 1996-10-10
PA8388101A1 (es) 1997-09-30

Similar Documents

Publication Publication Date Title
ATE228829T1 (de) Tablette mit gesteuerter freisetzung
ATE200864T1 (de) Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
DK0737738T3 (da) Blegemiddeltablet
ZA96448B (en) Tablet
EE04293B1 (et) Stabiilsed lüofiliseeritud ravimvormid
DE69732113D1 (de) Schnelllösliche tablette enthaltend galanthaminhydrobromid
DE69128569D1 (de) Tablette mit verzögerter Wirkstoffabgabe
DK0966287T3 (da) Oxacarbazepinfilmovertrukne tabletter
IL123614A0 (en) Chewable tablet
DE59604114D1 (de) Kautablette mit brausewirkung
DE69814850D1 (de) Paracetamol enthaltende schlickbare tablette
BR9610214A (pt) Compostos farmacéuticos
ATE300297T1 (de) Umhüllte tablette enthaltend trimebutin maleat
BR9600809A (pt) Medicamento
AU128017S (en) Pharmaceutical tablet
FR2737885B3 (fr) Distributeur de comprimes
DE69632787D1 (de) Pharmazeutische pellets
DK0818964T3 (da) Doseringsstift
AU129056S (en) Pharmaceutical tablet
BR9610193A (pt) 4-Tiocarbamoil-1-(2-Pirazolil)-pirazóis
NO965448D0 (no) Farmasöytiske forbindelser
ATE240096T1 (de) Schnellfreisetzende komprimierte flurbiprofen enthaltende tablette
KR970008018U (ko) 장제용 위패
UA1292S (uk) Таблетка фармацевтична
SE9500250D0 (sv) Portionstabletter

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties